Novus Therapeutics, Inc. Business Finance Contracts & Agreements
27 Contracts & Agreements
- Exchange Agreements (5 contracts)
- Investor Rights Agreements (1)
- Purchase Agreements (2)
- Registration Rights Agreements (2)
- Security Agreements (1)
- Share Agreements (2)
- Stock Agreements (7)
- Underwriting Agreements (1)
- Warrant Agreements (6)
- Registration Rights Agreement, dated May 6, 2024 (Filed With SEC on May 7, 2024)
- Securities Purchase Agreement, dated May 6, 2024 (Filed With SEC on May 7, 2024)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on May 7, 2024)
- Form of Amendment to Stock Option Agreement, dated December 30, 2023, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D., Steve Perrin, Ph D. and Paul Little (Filed With SEC on March 28, 2024)
- Form of Stock Option Agreement, dated May 1, 2023, between Eledon Pharmaceuticals, Inc. and each of David-Alexandre C. Gros, M.D., Steve Perrin, Ph D. and Paul Little (Filed With SEC on March 28, 2024)
- Series X1 Exchange Agreement, dated January 11, 2022, by and among Eledon Pharmaceuticals, Inc. and the Stockholders named therein (Filed With SEC on January 13, 2022)
- Warrant Exchange Agreement, dated December 31, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on January 7, 2021)
- Series X Exchange Agreement, dated December 31, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on January 7, 2021)
- Exchange Agreement, dated February 13, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein (Filed With SEC on February 19, 2020)
- Form of Warrant Exercise Agreement by and between Novus Therapeutics, Inc. and the Holders named therein (Filed With SEC on January 16, 2020)
- Form of Private Placement Warrant (Filed With SEC on January 16, 2020)
- Form of Securities Purchase Agreement, dated April 30, 2019, by and between Novus Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on May 2, 2019)
- Form of Placement Agent Warrant (Filed With SEC on May 2, 2019)
- Form of Warrant (Filed With SEC on May 2, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 4, 2018)
- Novus Therapeutics, Inc., 2014 Employee Stock Purchase Plan (Filed With SEC on August 7, 2018)
- NOVUS THERAPEUTICS, INC. Shares of Common Stock (par value $0.001 per share) Equity Distribution Agreement (Filed With SEC on August 22, 2017)
- Pursuant to 17 CFR 20.24b-2, confidential information has been omitted in places marked ***and has been filed separately with the Securities and Exchange Commission pursuant to a... (Filed With SEC on August 9, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 15, 2017)
- AMENDED AND RESTATED SHARE PURCHASE AGREEMENT by and among TOKAIPHARMACEUTICALS, INC., OTIC PHARMA, LTD. and SHAREHOLDERS OFOTIC PHARMA, LTD. Dated as of March 2, 2017 Effective... (Filed With SEC on March 3, 2017)
- TOKAI PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on February 3, 2017)
- SHARE PURCHASE AGREEMENT by and among TOKAIPHARMACEUTICALS, INC., OTIC PHARMA, LTD. and SHAREHOLDERS OFOTIC PHARMA, LTD. Dated as of December 21, 2016 TABLE OF CONTENTS (Filed With SEC on December 22, 2016)
- TOKAI PHARMACEUTICALS, INC. 2014EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on September 2, 2014)
- PLEASE INSERT SOCIAL SECURITY OR OTHER (Filed With SEC on September 2, 2014)
- [ ] Shares TOKAI PHARMACEUTICALS, INC. Common Stock UNDERWRITINGAGREEMENT (Filed With SEC on September 2, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. MASTER LICENSE AGREEMENT BETWEEN UNIVERSITY... (Filed With SEC on August 11, 2014)
- FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 11, 2014)
